Prognostic value of HER3, PTEN and p-HER2 expression in patients with HER2positive breast cancer

Prognostic value of HER3, PTEN and p-HER2 expression in patients with HER2positive breast cancer

HER2 overexpression is an unfavorable prognostic factor in patients with breast cancer, but it is also a target for the monoclonal antibody trastuzumab, which is effective in adjuvant and palliative settings. HER2 positivity is an inclusion criterion for immunotherapy, but it is not a positive predi...

Full description

Bibliographic Details
Main Authors: Sylwia Dębska-Szmich, Renata Kusińska, Urszula Czernek, Katarzyna Szydłowska-Pazera, Maja Habib-Lisik, Janusz H. Piekarski, Elżbieta Olas, Andrzej Kulig, Małgorzata Ułańska, Ewa Kalinka-Warzocha, Piotr Potemski
Format: Article
Language:English
Published: Index Copernicus International S.A. 2015-05-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
HER3
PTEN
phosphorylated HER2
HER2-positive breast cancer
Online Access:http://phmd.pl/gicid/01.3001.0009.6533

Internet

http://phmd.pl/gicid/01.3001.0009.6533

Similar Items